← back to search

Marie Karanian

Instituto Nacional de Cancerología · FR
Area of research
Pulmonary and Respiratory Medicine · Rheumatology
Research interest
Research interests include Sarcoma Diagnosis and Treatment, Bone Tumor Diagnosis and Treatments, Vascular Tumors and Angiosarcomas, and Soft tissue tumor case studies.
h-index
33
citations
3,509
works
145
NIH funding
primary concept
Medicine
email

Recent publications

Improved nationwide survival of sarcoma patients with a network of reference centers
Annals of Oncology 2024cited by 45position: middledoi
Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years
European Journal of Cancer 2023cited by 21position: middledoi
A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages
Cancers 2023cited by 16position: middledoi
Wholistic approach: Transcriptomic analysis and beyond using archival material for molecular diagnosis
Genes Chromosomes and Cancer 2022cited by 60position: middledoi
SELNET clinical practice guidelines for bone sarcoma
Critical Reviews in Oncology/Hematology 2022cited by 32position: middledoi
Intra‐ and extra‐cranial <scp><i>BCOR‐</i>ITD</scp> tumours are separate entities within the <scp><i>BCOR</i></scp>‐rearranged family
The Journal of Pathology Clinical Research 2022cited by 26position: middledoi
A Combination of MTAP and p16 Immunohistochemistry Can Substitute for <i>CDKN2A</i> Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural Mesotheliomas
Archives of Pathology & Laboratory Medicine 2022cited by 21position: middledoi
Expanding the molecular spectrum of tenosynovial giant cell tumors
Frontiers in Oncology 2022cited by 19position: middledoi
Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network
PLoS ONE 2021cited by 260position: middledoi
SELNET clinical practice guidelines for soft tissue sarcoma and GIST
Cancer Treatment Reviews 2021cited by 78position: middledoi
Superficial CD34‐positive fibroblastic tumor and <i>PRDM10</i>‐rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases
Histopathology 2021cited by 46position: middledoi
Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas
ESMO Open 2021cited by 27position: middledoi
Determinants of the access to remote specialised services provided by national sarcoma reference centres
BMC Cancer 2021cited by 19position: middledoi
Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial
The Lancet Oncology 2020cited by 88position: middledoi
NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker
Modern Pathology 2020cited by 58position: middledoi
SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma
The American Journal of Surgical Pathology 2020cited by 49position: firstdoi
Molecular Classification of Endometrial Stromal Sarcomas Using RNA Sequencing Defines Nosological and Prognostic Subgroups with Different Natural History
Cancers 2020cited by 35position: middledoi
Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee
Cancer Medicine 2020cited by 34position: middledoi
Soft Tissue Special Issue: Perivascular and Vascular Tumors of the Head and Neck
Head and Neck Pathology 2020cited by 31position: middledoi
SRF Fusions Other Than With RELA Expand the Molecular Definition of SRF-fused Perivascular Tumors
The American Journal of Surgical Pathology 2020cited by 25position: firstdoi
Surgery in reference centers improves survival of sarcoma patients: a nationwide study
Annals of Oncology 2019cited by 326position: middledoi
Integrated molecular characterization of chondrosarcoma reveals critical determinants of disease progression
Nature Communications 2019cited by 103position: middledoi
Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular Spectrum
The American Journal of Surgical Pathology 2019cited by 89position: middledoi
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial
The Lancet Oncology 2019cited by 79position: middledoi
Melanocytic tumors with MAP3K8 fusions: report of 33 cases with morphological-genetic correlations
Modern Pathology 2019cited by 64position: middledoi
Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report
Journal of Medical Case Reports 2019cited by 60position: middledoi
Malignant melanoma with areas of rhabdomyosarcomatous differentiation arising in a giant congenital nevus with RAF1 gene fusion
Pigment Cell & Melanoma Research 2019cited by 37position: middledoi
The immune landscape of chondrosarcoma - potential for therapeutic targeting of CSFR1+ macrophages
Journal of bone oncology 2019cited by 37position: middledoi
Very long‐term survivors among patients with metastatic soft tissue sarcoma
Cancer Medicine 2019cited by 28position: middledoi
Transcriptomic definition of molecular subgroups of small round cell sarcomas
The Journal of Pathology 2018cited by 328position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Franck Tirode · Cancer Research Center15 papers (2018–2022)Daniel Pissaloux · Université Claude Bernard Lyon 111 papers (2018–2022)Jean‐Yves Blay · International Network for Economic, Social and Cultural Rights11 papers (2019–2023)François Le Loarer · Université Claude Bernard Lyon 17 papers (2018–2022)Jean‐Michel Coindre · KU Leuven5 papers (2018–2021) · 5 papers (2020–2022)Armelle Dufresne · Media Working Group5 papers (2019–2022)Mehdi Brahmi · Centre Léon Bérard5 papers (2019–2022)Sandrine Paindavoine · Université Claude Bernard Lyon 14 papers (2020–2022)Amine Bouhamama · Université Claude Bernard Lyon 13 papers (2019–2022)Isabelle Soubeyran · Institut Bergonié3 papers (2019–2021)Nadège Corradini · Centre de Recherche en Cancérologie de Lyon3 papers (2020–2022) · 3 papers (2018–2020)Hélène Vanacker · Université Claude Bernard Lyon 13 papers (2020–2022) · 3 papers (2019–2021) · 3 papers (2019–2020)Aurélie Houlier · Université Claude Bernard Lyon 13 papers (2019–2022)Adeline Duc · Université Claude Bernard Lyon 13 papers (2020–2022)Arnaud de la Fouchardière · Université Claude Bernard Lyon 13 papers (2019–2022) · 3 papers (2020–2020)